From Bioblast
<nowiki>
FR Toulouse Dray C
| O2k-Network Lab | INSERM U 1048, équipe n°3
Institut des Maladies Métaboliques et Cardiovasculaires |
|---|---|
| Address | 1 Avenue du Professeur Jean Poulhes, 31400 |
| City | Toulouse |
| State/Prov | |
| Country | France |
| Weblink | |
| Contact | Dray C |
| Team | |
| Team previous | |
| Status | O2k 2015- |
| Oroboros Events | |
| Topics |
O2k-Publications
| Published | Reference | |
|---|---|---|
| Valet 2015 US Patent | 2015 | Valet P, Dray C, Knauf C, Kunduzova O, Castan-Laurell I (2015) Pharmaceutical composition for use in the treatment of dysfunction associated with aging. US Patent US20150290286 A1. |
| Attane 2012 Diabetes | 2012 | Attané C, Foussal C, Le Gonidec S, Benani A, Daviaud D, Wanecq E, Guzmán-Ruiz R, Dray C, Bezaire V, Rancoule C, Kuba K, Ruiz-Gayo M, Levade T, Penninger J, Burcelin R, Pénicaud L, Valet P, Castan-Laurell I (2012) Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice. Diabetes 61:310-20. |
| Knauf 2008 Endocrinology | 2008 | Knauf C, Cani PD, Ait-Belgnaoui A, Benani A, Dray C, Cabou C, Colom A, Uldry M, Rastrelli S, Sabatier E, Godet N, Waget A, Pénicaud L, Valet P, Burcelin R (2008) Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure. Endocrinology 149:4768-77. |
O2k-Abstracts
update please
